Tissue Plasminogen Activator Modulates the Cellular and Behavioral Response to Cocaine

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2009 Feb 3

PMID 19181855

Citations 20

Authors

Rajani Maiya

Yan Zhou

Erin H Norris

Mary Jeanne Kreek

Sidney Strickland

Affiliations

Soon will be listed here.

Abstract

Cocaine exposure induces long-lasting molecular and structural adaptations in the brain. In this study, we show that tissue plasminogen activator (tPA), an extracellular protease involved in neuronal plasticity, modulates the biochemical and behavioral response to cocaine. When injected in the acute binge paradigm, cocaine enhanced tPA activity in the amygdala, which required activation of corticotropin-releasing factor type-1 (CRF-R1) receptors. Compared with WT mice, tPA-/- mice injected with cocaine displayed attenuated phosphorylation of ERK, cAMP response element binding protein (CREB), and dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and blunted induction of immediate early genes (IEGs) c-Fos, Egr-1, and Homer 1a in the amygdala and the nucleus accumbens (NAc). tPA-/- mice also displayed significantly higher basal preprodynorphin (ppDyn) mRNA levels in the NAc in comparison to WT mice, and cocaine decreased ppDyn mRNA levels in tPA-/- mice only. Cocaine-induced locomotor sensitization and conditioned place preference (CPP) were attenuated in tPA-/- mice. Cocaine exposure also had an anxiolytic effect in tPA-/- but not WT mice. These results identify tPA as an important and novel component of the signaling pathway that modulates cocaine-induced changes in neuroadaptation and behavior.

Citing Articles

Role and action mechanisms of tPA in CRH-induced apoptosis of mouse oviductal epithelial and mural granulosa cells.

Yang Y, Zhang M, Hua Q, Ma R, Wang X, Yuan H J Reprod Dev. 2024; 70(4):238-246.

PMID: 38910127 PMC: 11310383. DOI: 10.1262/jrd.2024-028.

Dynamic regulation of the extracellular matrix in reward memory processes: a question of time.

Valeri J, Gisabella B, Pantazopoulos H Front Cell Neurosci. 2023; 17:1208974.

PMID: 37396928 PMC: 10311570. DOI: 10.3389/fncel.2023.1208974.

PKCδ-positive GABAergic neurons in the central amygdala exhibit tissue-type plasminogen activator: role in the control of anxiety.

Douceau S, Lemarchand E, Hommet Y, Lebouvier L, Josephine C, Bemelmans A Mol Psychiatry. 2022; 27(4):2197-2205.

PMID: 35145231 DOI: 10.1038/s41380-022-01455-4.

The Fibrinolytic System: Mysteries and Opportunities.

Medcalf R, Keragala C Hemasphere. 2021; 5(6):e570.

PMID: 34095754 PMC: 8171360. DOI: 10.1097/HS9.0000000000000570.

Blockade of alcohol excessive and "relapse" drinking in male mice by pharmacological cryptochrome (CRY) activation.

Zhou Y, Kreek M Psychopharmacology (Berl). 2021; 238(4):1099-1109.

PMID: 33420591 PMC: 7969462. DOI: 10.1007/s00213-020-05757-9.

References

Nagai T, Yamada K, Yoshimura M, Ishikawa K, Miyamoto Y, Hashimoto K . The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci U S A. 2004; 101(10):3650-5. PMC: 373517. DOI: 10.1073/pnas.0306587101. View

Svenningsson P, Nairn A, Greengard P . DARPP-32 mediates the actions of multiple drugs of abuse. AAPS J. 2005; 7(2):E353-60. PMC: 2750972. DOI: 10.1208/aapsj070235. View

Nestler E . Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci. 2004; 25(4):210-8. DOI: 10.1016/j.tips.2004.02.005. View

Kreek M, Koob G . Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 1998; 51(1-2):23-47. DOI: 10.1016/s0376-8716(98)00064-7. View

Zhang Y, Butelman E, Schlussman S, Ho A, Kreek M . Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice. Psychopharmacology (Berl). 2004; 172(4):422-9. DOI: 10.1007/s00213-003-1688-3. View

Centonze D, Napolitano M, Saulle E, Gubellini P, Picconi B, Martorana A . Tissue plasminogen activator is required for corticostriatal long-term potentiation. Eur J Neurosci. 2002; 16(4):713-21. DOI: 10.1046/j.1460-9568.2002.02106.x. View

Pawlak R, Magarinos A, Melchor J, McEwen B, Strickland S . Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat Neurosci. 2003; 6(2):168-74. DOI: 10.1038/nn998. View

Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol J . Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A. 2004; 102(2):491-6. PMC: 544317. DOI: 10.1073/pnas.0408305102. View

Norris E, Strickland S . Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system. Proc Natl Acad Sci U S A. 2007; 104(33):13473-8. PMC: 1948906. DOI: 10.1073/pnas.0705848104. View

10.

Spangler R, Unterwald E, Kreek M . 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Brain Res Mol Brain Res. 1993; 19(4):323-7. DOI: 10.1016/0169-328x(93)90133-a. View

11.

Valjent E, Aubier B, Corbille A, Brami-Cherrier K, Caboche J, Topilko P . Plasticity-associated gene Krox24/Zif268 is required for long-lasting behavioral effects of cocaine. J Neurosci. 2006; 26(18):4956-60. PMC: 6674157. DOI: 10.1523/JNEUROSCI.4601-05.2006. View

12.

Koob G, Kreek M . Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007; 164(8):1149-59. PMC: 2837343. DOI: 10.1176/appi.ajp.2007.05030503. View

13.

Richter R, Pich E, Koob G, Weiss F . Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett. 1995; 187(3):169-72. DOI: 10.1016/0304-3940(95)11365-4. View

14.

Spanagel R, Herz A, Shippenberg T . Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A. 1992; 89(6):2046-50. PMC: 48593. DOI: 10.1073/pnas.89.6.2046. View

15.

Lu L, Koya E, Zhai H, Hope B, Shaham Y . Role of ERK in cocaine addiction. Trends Neurosci. 2006; 29(12):695-703. DOI: 10.1016/j.tins.2006.10.005. View

16.

Zhou Y, Spangler R, LaForge K, Maggos C, Ho A, Kreek M . Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther. 1996; 279(1):351-8. View

17.

Nagai T, Ito M, Nakamichi N, Mizoguchi H, Kamei H, Fukakusa A . The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1. J Neurosci. 2006; 26(47):12374-83. PMC: 6675418. DOI: 10.1523/JNEUROSCI.3139-06.2006. View

18.

Knoll A, Meloni E, Thomas J, Carroll F, Carlezon Jr W . Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther. 2007; 323(3):838-45. DOI: 10.1124/jpet.107.127415. View

19.

Hashimoto T, Kajii Y, Nishikawa T . Psychotomimetic-induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain. Eur J Neurosci. 1998; 10(11):3387-99. DOI: 10.1046/j.1460-9568.1998.00343.x. View

20.

Zhang Y, Svenningsson P, Picetti R, Schlussman S, Nairn A, Ho A . Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32. J Neurosci. 2006; 26(10):2645-51. PMC: 6675152. DOI: 10.1523/JNEUROSCI.3923-05.2006. View